X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-01 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale+OE | $39.80 | -5,110 | 284,733 | -2% | -$203,378 | |||||
2025-09-03 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $37.87 | -2,725 | 233,548 | -1% | -$103,198 | ||||||
2025-08-06 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $37.78 | -2,725 | 236,273 | -1% | -$102,951 | ||||||
| D | 2025-07-02 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale+OE | $45.09 | -10,090 | 238,998 | -4% | -$454,954 | |||||
2025-06-04 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $36.96 | -2,725 | 241,723 | -1% | -$100,716 | ||||||
2025-05-07 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $35.75 | -2,725 | 244,448 | -1% | -$97,419 | ||||||
2025-04-02 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $36.22 | -3,860 | 247,173 | -2% | -$139,801 | ||||||
2025-03-05 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $30.48 | -1,590 | 251,033 | -1% | -$48,463 | ||||||
2025-03-05 | APGE | Henderson Michael Thomas | CEO | S - Sale | $30.15 | -10,000 | 1,292,987 | -1% | -$301,511 | ||||||
| D | 2025-02-05 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale+OE | $40.69 | -3,520 | 252,623 | -1% | -$143,229 | |||||
2025-02-05 | APGE | Henderson Michael Thomas | CEO | S - Sale | $40.58 | -15,000 | 1,302,987 | -1% | -$608,700 | ||||||
2025-01-08 | APGE | Henderson Michael Thomas | CEO | S - Sale | $48.85 | -15,000 | 1,309,487 | -1% | -$732,693 | ||||||
| D | 2025-01-02 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale+OE | $46.94 | -4,085 | 255,348 | -2% | -$191,740 | |||||
2024-12-12 | APGE | McKenna Mark C. | Dir | P - Purchase | $49.54 | +20,000 | 20,000 | New | +$990,775 | ||||||
| D | 2024-12-11 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale+OE | $48.76 | -4,540 | 258,073 | -2% | -$221,363 | |||||
2024-12-04 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $46.07 | -6,665 | 260,798 | -2% | -$307,057 | ||||||
2024-12-04 | APGE | Henderson Michael Thomas | CEO | S - Sale | $46.58 | -15,000 | 1,324,487 | -1% | -$698,654 | ||||||
2024-11-06 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $59.12 | -6,665 | 267,463 | -2% | -$394,041 | ||||||
2024-11-06 | APGE | Henderson Michael Thomas | CEO | S - Sale | $59.22 | -15,000 | 1,339,487 | -1% | -$888,320 | ||||||
2024-10-02 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $56.26 | -6,665 | 274,128 | -2% | -$374,954 | ||||||
2024-10-02 | APGE | Henderson Michael Thomas | CEO | S - Sale | $56.23 | -40,000 | 1,354,487 | -3% | -$2,249,307 | ||||||
2024-09-04 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $47.56 | -6,665 | 280,793 | -2% | -$316,969 | ||||||
2024-09-04 | APGE | Henderson Michael Thomas | CEO | S - Sale | $47.62 | -40,000 | 1,394,487 | -3% | -$1,904,841 | ||||||
2024-08-23 | APGE | Henderson Jane | CFO | S - Sale | $48.26 | -6,000 | 200,871 | -3% | -$289,560 | ||||||
2024-08-07 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $40.67 | -7,335 | 287,458 | -2% | -$298,336 | ||||||
2024-08-07 | APGE | Henderson Michael Thomas | CEO | S - Sale | $40.62 | -40,000 | 1,434,487 | -3% | -$1,624,764 | ||||||
2024-07-05 | APGE | Henderson Michael Thomas | CEO | S - Sale | $37.26 | -15,000 | 1,474,487 | -1% | -$558,900 | ||||||
2024-07-03 | APGE | Dambkowski Carl | Chief Medical Officer | S - Sale | $37.60 | -5,995 | 294,793 | -2% | -$225,418 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |